ADVERTISEMENTs
Indian firm gets US FDA nod for brain tumors detection test
'TriNetraâ„¢-Glio' developed by Datar Cancer Genetics is a form of liquid biopsy which tests cells in the blood from brain tumors which are extremely rare and hard to detect
-
Sanjeev Kumar
- Tue, 03, Jan 2023
- 09:45 EST
- 457
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
E Paper
ADVERTISEMENT
.jpg)
Video
.jpg)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login